Influence of the cerebrospinal fluid laboratory parameters in the ELISA test for neurocysticercosis using a total cysticerci antigen

被引:3
作者
Casanova, CS
Ribeiro, MJSP
Gonçalves, RR
Faria, LC
Peralta, JM
Puccioni-Sohler, M
机构
[1] Fed Univ Rio de Janeiro, Gaffree Guinle Univ Hosp, Neurol Serv, HUGG UNIRO,Neurolife Lab, Rio De Janeiro, Brazil
[2] UFRJ, HUCFF, SPC, Neurolife Lab, Rio De Janeiro, Brazil
[3] UFRJ, Inst Microbiol, Rio De Janeiro, Brazil
关键词
cerebrospinal fluid; enzyme linked immunosorbent assay; neurocysticercosis;
D O I
10.1590/S0004-282X2006000100012
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
To evaluate if the cerebrospinal fluid (CSF) parameters may influence the cysticercosis immunoreactivity response in the CSF. CSF samples of 109 patients were analyzed and classified in three groups, according to the neurological manifestations and the reactivity in antibody-enzyme linked immunosorbent assay (Ab-ELISA) testing in CSF for neurocysticercosis (NC) group A, 18 patients with neurological disorders compatible with NC and reactive Ab-ELISA in CSF for NC; group B, 50 patients with neurological disorders non-compatible with NC and reactive Ab-ELISA for NC; group C, 41 patients with neurological disorders non-compatible with NC and non-reactive Ab-ELISA in CSF for NC. The CSF analysis in group A was compatible with NC. The group B in comparison to the groups A and C presents higher frequency and intensity of hypercytosis, presence of red blood cells in CSF, protein concentration and immunological reactive test for other etiological agents (p <= 0.05). Based on the present data, we suggest that the inflammatory process and high protein concentration may determine false positive reactions in the Ab-ELISA test for NC in the CSF.
引用
收藏
页码:55 / 59
页数:5
相关论文
共 20 条
[1]  
Adams RD, 2001, PRINCIPLES NEUROLOGY
[2]  
Bueno EC, 2000, J CLIN MICROBIOL, V38, P146
[3]   Proposed diagnostic criteria for neurocysticercosis [J].
Del Brutto, OH ;
Rajshekhar, V ;
White, AC ;
Tsang, VCW ;
Nash, TE ;
Takayanagui, OM ;
Schantz, PM ;
Evans, CAW ;
Flisser, A ;
Correa, D ;
Botero, D ;
Allan, JC ;
Sarti, E ;
Gonzalez, AE ;
Gilman, RH ;
García, HH .
NEUROLOGY, 2001, 57 (02) :177-183
[4]   Immunodiagnostic tools for human and porcine cysticercosis [J].
Dorny, P ;
Brandt, J ;
Zoli, A ;
Geerts, S .
ACTA TROPICA, 2003, 87 (01) :79-86
[5]   Sensitivity and specificity of ELISA and immunoblot for diagnosing neurocysticercosis [J].
Gekeler, F ;
Eichenlaub, S ;
Mendoza, EG ;
Sotelo, J ;
Hoelscher, M ;
Löscher, T .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 2002, 21 (03) :227-229
[6]   Novel antigens for neurocysticercosis: Simple method for preparation and evaluation for serodiagnosis [J].
Ito, A ;
Plancarte, A ;
Ma, L ;
Kong, Y ;
Flisser, A ;
Cho, SY ;
Liu, YH ;
Kamhawi, S ;
Lightowlers, MN ;
Schantz, PM .
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 1998, 59 (02) :291-294
[7]  
Katti MK, 2002, FEMS IMMUNOL MED MIC, V33, P57, DOI 10.1111/j.1574-695X.2002.tb00573.x
[8]  
LARRALDE C, 1990, ARCH PATHOL LAB MED, V114, P926
[9]   IgG intrathecal synthesis and specific antibody index in patients with neurocysticercosis [J].
Machado, LR ;
Livramento, JA ;
Vaz, AJ ;
Bueno, EC ;
Mielli, SR ;
Bastouly, V ;
Nóbrega, JPS .
ARQUIVOS DE NEURO-PSIQUIATRIA, 2002, 60 (2B) :395-399
[10]   Recommended diagnostic criteria for multiple sclerosis: Guidelines from the International Panel on the Diagnosis of Multiple Sclerosis [J].
McDonald, WI ;
Compston, A ;
Edan, G ;
Goodkin, D ;
Hartung, HP ;
Lublin, FD ;
McFarland, HF ;
Paty, DW ;
Polman, CH ;
Reingold, SC ;
Sandberg-Wollheim, M ;
Sibley, W ;
Thompson, AJ ;
van den Noort, S ;
Weinshenker, BY ;
Wolinsky, JS .
ANNALS OF NEUROLOGY, 2001, 50 (01) :121-127